Standard clinical assays can obscure the diversity of breast cancer subtypes

[News]

Classification systems that categorize breast cancers based on estrogen receptor (ER), progesterone receptor (PR), and HER2 expression levels may obscure the heterogeneity of other key tumor...

More... (http://www.medicalnewstoday.com/releases/293006.php)